ID

7918

Beskrivning

TAILORx Second Primary Form Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A3BB68BA-CCE2-8DF9-E040-BB89AD43631B

Länk

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A3BB68BA-CCE2-8DF9-E040-BB89AD43631B

Nyckelord

Clinical Trial

C50-C50.9

D005500

2012-08-26 2012-08-26 -
2015-01-09 2015-01-09 - Martin Dugas

Uppladdad den

9 januari 2015

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0 Legacy

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Breast Cancer NCT00310180 Follow-Up - TAILORx Second Primary Form - 3236572v1.0

Detaljer

No Instruction available.

1 Formulär

StudyEvent: TAILORx Second Primary Form
1. No Instruction available.

Header

ECOG Protocol Number

ECOG Patient ID

DCI Name

Registration Step

Reporting Period

Second Primary Cancer (Second primary)

Completed By Central Lab

Date of Diagnosis of Second Primary Cancer (mm/dd/yyyy)

Site of Second Primary Cancer

Acute Lymphocytic Leukemia (Acute Lymphocytic Leukemia (ALL))

Acute Myelogenous Leukemia (Acute Myelogenous Leukemia (AML))

Adrenal (Adrenal)

Aids-related Lymphoma (AIDS-related Lymphoma)

50 fler Item i detaljvyn.

Include information on histologic subtype (s Please attach copies of any corroborating pathology reports.)

Comments

Investigator Signature

Investigator Signature Date

Tillbaka till toppen

Similar models

Show recommended models

ID